United States· US:50474-992_49eeeabf-4c62-63cb-e063-6394a90a8248
ZILBRYSQ
A zilucoplan product containing zilucoplan, registered in United States by UCB, Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Zilucoplan is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AJ06 (zilucoplan), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Zilucoplan · ATC L04AJ06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ZILUCOPLAN
- Manufacturer
- UCB, Inc.
- Country
- United States (US)
- ATC code
- L04AJ06
- ATC class
- Zilucoplan
- Defined daily dose
- 23 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1150474992804 CARTON in 1 BOX (50474-992-80) / 7 SYRINGE, GLASS in 1 CARTON / .81 mL in 1 SYRINGE, GLASS
- ndc1150474-992-80
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zilucoplan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZILBRYSQUCB Pharma SA, Brusel
- BelgiumZilbrysq 16.6 mgUCB Pharma
- SpainZILBRYSQ 16,6 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAUcb Pharma
- FinlandZilbrysqUCB Pharma SA
- NetherlandsZilbrysq 16,6 mg oplossing voor injectie in een voorgevulde penUCB Pharma S.A.
- SwedenZILBRYSQ 16,6 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- PolandZilbrysqUCB Pharma S.A.
- United KingdomZilbrysq 16.6mg/0.416ml solution for injection pre-filled syringesUCB Pharma Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zilbrysq
- Liechtenstein · Zilbrysq
- Norway · Zilbrysq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7dbaf58e-42ab-475c-810b-f3ed3ac37a6b GET /v1/drugs/7dbaf58e-42ab-475c-810b-f3ed3ac37a6b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "40",
"substance": "ZILUCOPLAN",
"productndc": "50474-992",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA216834",
"marketing_category": "NDA"
}See everything about zilucoplan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.